Enanta Pharmaceuticals Inc financial data

Symbol
ENTA on Nasdaq
Industry
Pharmaceutical Preparations
Location
4 Kingsbury Avenue, Watertown, MA
Fiscal year end
September 30
Latest financial report
10-K - Q3 2024 - Nov 27, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 570 % -25.5%
Debt-to-equity 154 % +161%
Return On Equity -73 % -39.8%
Return On Assets -28.7 % +12.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21.2M shares +0.64%
Common Stock, Shares, Outstanding 21.2M shares +0.64%
Entity Public Float 347M USD -56.6%
Common Stock, Value, Issued 212K USD +0.47%
Weighted Average Number of Shares Outstanding, Basic 21.2M shares +0.9%
Weighted Average Number of Shares Outstanding, Diluted 21.2M shares +0.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 67.6M USD -14.6%
Research and Development Expense 131M USD -19.6%
General and Administrative Expense 57.9M USD +9.38%
Costs and Expenses 189M USD -12.5%
Operating Income (Loss) -122M USD +11.3%
Nonoperating Income (Expense) 3.9M USD -37.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -118M USD +10.1%
Income Tax Expense (Benefit) -1.74M USD -162%
Net Income (Loss) Attributable to Parent -116M USD +13.3%
Earnings Per Share, Basic -5.48 USD/shares +14.1%
Earnings Per Share, Diluted -5.48 USD/shares +14.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37.2M USD -56.4%
Accounts Receivable, after Allowance for Credit Loss, Current 6.65M USD -22.8%
Assets, Current 300M USD -29.1%
Property, Plant and Equipment, Net 32.7M USD +174%
Operating Lease, Right-of-Use Asset 40.7M USD +78.4%
Other Assets, Noncurrent 94K USD -88.3%
Assets 377M USD -18.5%
Accounts Payable, Current 8M USD +95.3%
Employee-related Liabilities, Current 6.57M USD -6.64%
Accrued Liabilities, Current 13.5M USD -26.1%
Liabilities, Current 57.5M USD -8.37%
Operating Lease, Liability, Noncurrent 53.9M USD +154%
Other Liabilities, Noncurrent 231K USD -65.2%
Liabilities 248M USD +0.94%
Accumulated Other Comprehensive Income (Loss), Net of Tax 302K USD
Retained Earnings (Accumulated Deficit) -323M USD -56.1%
Stockholders' Equity Attributable to Parent 129M USD -40.6%
Liabilities and Equity 377M USD -18.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25M USD +29.9%
Net Cash Provided by (Used in) Financing Activities -7.35M USD -2542%
Net Cash Provided by (Used in) Investing Activities -13.1M USD -139%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 21.2M shares +0.64%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -45.5M USD -2467%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.14M USD
Deferred Tax Assets, Valuation Allowance 127M USD +10.5%
Deferred Tax Assets, Gross 141M USD +15.3%
Operating Lease, Liability 55.5M USD +109%
Payments to Acquire Property, Plant, and Equipment 787K USD -75.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -115M USD +12.7%
Lessee, Operating Lease, Liability, to be Paid 94.7M USD +174%
Property, Plant and Equipment, Gross 57.7M USD +61.9%
Operating Lease, Liability, Current 1.52M USD -71.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.47M USD +59.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.7M USD +29.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +27.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 33M USD +312%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.72M USD +62.3%
Deferred Tax Assets, Operating Loss Carryforwards 7.27M USD +16816%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 905K USD -14.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.98M USD +72.9%
Operating Lease, Payments 76.5K USD
Deferred Tax Assets, Net of Valuation Allowance 14.2M USD +87.1%
Share-based Payment Arrangement, Expense 26.8M USD -5.04%
Interest Expense 2.36M USD +17.9%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%